Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder (FRIENDS)

Abbott

Status: Completed

Conditions: Depression

Study type: Observational

Funder types: NETWORK; Industry

Identifiers

NCT02043197

P14-326

Details and patient eligibility

About

Prospective, multicenter, non-comparative, observational program to describe prevalence of depressive symptoms in a variety of neurological disorders and effects of Fevarin® on the severity of anxiety and depression, sleep state, and cognitive function.

Enrollment: 300 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Outpatients with neurological disorders and mild or moderate symptoms of depression with Hospital Anxiety Depression Scale (HADS) depression scale score of 8 and higher. Fevarin® prescribed not earlier than 7 days before Visit 1.

Exclusion criteria

• Labeled contraindications to Fevarin®, psychotic symptoms and/or suicidal ideation, schizophrenia, bipolar disorder, schizoaffective disorder, severe dementia, alcohol or drug abuse, acute neurological disorders.

Trial design

300 participants in 1 patient group

Outpatients with neurological disorders and depression.

Description:

Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label.